|
COIL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.597200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.523430E-01 |
| Normal-vs-Stage2 |
2.337600E-01 |
| Normal-vs-Stage3 |
5.673900E-02 |
| Normal-vs-Stage4 |
6.457900E-02 |
| Stage1-vs-Stage2 |
7.968400E-01 |
| Stage1-vs-Stage3 |
2.543400E-01 |
| Stage1-vs-Stage4 |
4.366400E-02 |
| Stage2-vs-Stage3 |
5.074000E-01 |
| Stage2-vs-Stage4 |
1.816160E-01 |
| Stage3-vs-Stage4 |
2.851400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.174460E-02 |
| Normal-vs-AfricanAmerican |
2.848200E-01 |
| Normal-vs-Asian |
1.669630E-01 |
| Caucasian-vs-AfricanAmerican |
2.539400E-01 |
| Caucasian-vs-Asian |
3.767800E-01 |
| AfricanAmerican-vs-Asian |
1.022770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.040030E-01 |
| Normal-vs-Female |
6.000900E-04 |
| Male-vs-Female |
1.758480E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.701390E-01 |
| Normal-vs-Extreme_Weight |
4.470400E-01 |
| Normal-vs-Obese |
8.788300E-02 |
| Normal-vs-Extreme_Obese |
8.390200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.960800E-01 |
| Normal_Weight-vs-Obese |
8.949600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.614200E-01 |
| Extreme_Weight-vs-Obese |
3.813000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.544800E-01 |
| Obese-vs-Extreme_Obese |
3.433200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.649600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.282860E-03 |
| Normal-vs-Age(61-80Yrs) |
3.674800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.667000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.341770E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.638900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.337130E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.354100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.484200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.884000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.206490E-02 |
| Normal-VS-Type2 PRCC |
9.401600E-01 |
| Normal-VS-KIRP CIMP |
1.103770E-02 |
| Normal-VS-Unclassified PRCC |
9.021900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.019700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.311900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.941200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.519200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.302210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.262580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.051000E-01 |
| Normal-vs-N1 |
4.564400E-03 |
| Normal-vs-N2 |
5.352600E-01 |
| N0-vs-N1 |
5.757400E-03 |
| N0-vs-N2 |
4.392000E-01 |
| N1-vs-N2 |
4.004800E-01 |
|
|
